News

Developed in collaboration with pharma and biotechnology companies, the Cellaxess platform enables scalable field stimulation, compound delivery and transfection for genomic screening of primary cells, neurones and stem

C16G2 is a synthetic peptide derived from C3 Jian’s proprietary Specifically Targeted Antimicrobial Peptides (STAMPS) technology which has demonstrated activity selectively targeting Streptococcus mutans, a cavity-causing organism. The

The product, launched by Mylan’s subsidiaries based in the UK and Italy, is the generic version of Roche’s Bonviva Tablets. Mylan CEO Heather Bresch said, "We are excited

The transaction is likely to close by June 2012, subject to certain closing conditions and is anticipated to be accretive in 2012. Valeant chairman and chief executive officer

The generic equivalent to Medpointe Pharm’s Astelin nasal spray is indicated to treat the symptoms of seasonal allergic rhinitis such as rhinorrhea, sneezing and nasal pruritus. The product

The FDA approved Nevirapine tablets of 200mg strength and Nevirapine oral suspension of 50mg/5ml strength, the company said. The drug is used as a part of antiretroviral combination

As per the agreement, APP acquires complete ownership and becomes the abbreviated new drug application holder of the products. APP president and chief executive officer John Ducker said,

Enhanced by OneKey, the Customer Relationship Management (CRM) solution will enable the company to maintain better relationships with stakeholders. The Mobile Intelligence solution provides better governance through deeper

Otsuka Pharmaceutical, which has licensed the US commercialization rights to the product, will fund the clinical program. GW R&D director Stephen Wright said, "This clinical development programme, being